These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28400594)

  • 1. Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy.
    Jiang X; Liu Y; Tan M
    Emerg Microbes Infect; 2017 Apr; 6(4):e22. PubMed ID: 28400594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus: Genetics, pathogenesis and vaccine advances.
    Sadiq A; Bostan N; Yinda KC; Naseem S; Sattar S
    Rev Med Virol; 2018 Nov; 28(6):e2003. PubMed ID: 30156344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
    Alfajaro MM; Kim JY; Barbé L; Cho EH; Park JG; Soliman M; Baek YB; Kang MI; Kim SH; Kim GJ; Park SI; Pendu JL; Cho KO
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding specificity of P[8] VP8* proteins of rotavirus vaccine strains with histo-blood group antigens.
    Sun X; Guo N; Li D; Jin M; Zhou Y; Xie G; Pang L; Zhang Q; Cao Y; Duan ZJ
    Virology; 2016 Aug; 495():129-35. PubMed ID: 27209447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus virus-like particles (RV-VLPs) vaccines: An update.
    Changotra H; Vij A
    Rev Med Virol; 2017 Nov; 27(6):. PubMed ID: 29048711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges to Developing a Rotavirus Vaccine.
    Offit PA
    Viral Immunol; 2018 Mar; 31(2):104-108. PubMed ID: 29265955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
    Lee B; Dickson DM; deCamp AC; Ross Colgate E; Diehl SA; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Taniuchi M; Petri WA; Haque R; Qadri F; Kirkpatrick BD
    J Infect Dis; 2018 Apr; 217(9):1399-1407. PubMed ID: 29390150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccines: current status and future considerations.
    Yen C; Tate JE; Hyde TB; Cortese MM; Lopman BA; Jiang B; Glass RI; Parashar UD
    Hum Vaccin Immunother; 2014; 10(6):1436-48. PubMed ID: 24755452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus VP6 preparations as a non-replicating vaccine candidates.
    Jalilvand S; Marashi SM; Shoja Z
    Vaccine; 2015 Jun; 33(29):3281-7. PubMed ID: 26021725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus VP6 as a potential vaccine candidate.
    Afchangi A; Jalilvand S; Mohajel N; Marashi SM; Shoja Z
    Rev Med Virol; 2019 Mar; 29(2):e2027. PubMed ID: 30614135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem?
    Glass RI; Jiang B; Parashar U
    Vaccine; 2018 Apr; 36(17):2233-2236. PubMed ID: 29567032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccines in clinical development: Current pipeline and state-of-the-art.
    Sartorio MUA; Folgori L; Zuccotti G; Mameli C
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():58-60. PubMed ID: 32017224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Group C Rotavirus VP8*s Recognize Type A Histo-Blood Group Antigens as Ligands.
    Sun X; Wang L; Qi J; Li D; Wang M; Cong X; Peng R; Chai W; Zhang Q; Wang H; Wen H; Gao GF; Tan M; Duan Z
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants.
    Bucardo F; Reyes Y; Rönnelid Y; González F; Sharma S; Svensson L; Nordgren J
    Sci Rep; 2019 Jul; 9(1):10764. PubMed ID: 31341254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.
    Mahmud-Al-Rafat A; Muktadir A; Muktadir H; Karim M; Maheshwari A; Ahasan MM
    Infection; 2018 Feb; 46(1):15-24. PubMed ID: 29047020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histo-blood group antigens as divergent factors of groups A and C rotaviruses circulating in humans and different animal species.
    Zhao D; Liu Y; Huang P; Xia M; Li W; Tan M; Zhang X; Jiang X
    Emerg Microbes Infect; 2020 Dec; 9(1):1609-1617. PubMed ID: 32543972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vaccination on the molecular epidemiology and evolution of group A rotaviruses in Latin America and factors affecting vaccine efficacy.
    Bucardo F; Nordgren J
    Infect Genet Evol; 2015 Aug; 34():106-13. PubMed ID: 26079278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants.
    El-Heneidy A; Cheung C; Lambert SB; Wang CYT; Whiley DM; Sly PD; Ware RS; Grimwood K
    Pathology; 2022 Dec; 54(7):928-934. PubMed ID: 35817636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.